Loading company…
Z Factor Ltd discovers therapeutic agents to treat Alpha-1-antitrypsin deficiency.
Z Factor Ltd discovers therapeutic agents aimed at Alpha-1-antitrypsin deficiency. Established in 2015 and based in Cambridge, UK, the company's listed stage is Series A.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in